US Patent Issued to Celcuity on July 8 for "Methods for the treatment of cancer using 1-(4-{[4-(dimethylamino)piperidin-1-ylcarbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenylurea" (Minnesota Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,350,276, issued on July 8, was assigned to Celcuity Inc. (Minneapolis).

"Methods for the treatment of cancer using 1-(4-{[4-(dimethylamino)piperidin-1-ylcarbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenylurea" was invented by Brian Francis Sullivan (Medina, Minn.) and Lance Gavin Laing (Orono, Minn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are methods of treating cancer in a human subject. The method includes selecting a subject in need of treatment of cancer; administering to the subject a therapeutically effective amount of gedatolisib at least once a week for a period of three weeks; discontinuing administration of ged...